A1 Journal article – refereed

In-Vivo Bone-Targeting of Bis(phosphonate)-Conjugated Double Helical RNA Monitored by Positron Emission Tomography

List of Authors: Satish Jadhav, Meeri Käkelä, Matthieu Bourgery, Kiira Rimpilä, Heidi Liljenbäck, Riikka Siitonen, Jussi Mäkilä, Tiina Laitala-Leinonen, Päivi Poijärvi-Virta, Harri Lönnberg, Anne Roivainen, Pasi Virta


Publication year: 2016

Journal: Molecular Pharmaceutics

Journal name in source: MOLECULAR PHARMACEUTICS

Journal acronym: MOL PHARMACEUT

Volume number: 13

Issue number: 7

Number of pages: 8

ISSN: 1543-8384

DOI: http://dx.doi.org/10.1021/acs.molpharmaceut.6b00261

A bis(phosphonate) conjugate of 2'-O-methyl oligoribonucleotide (microRNA-21) was synthesized and used as a bone-targeting carrier in the systemic delivery of a Ga-68-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)chelated 2'-O-methyl oligoribonucleotide (anti-microRNA-21). The whole-body biodistribution of the double helical RNA was monitored by positron emission tomography (PET), which verified the expected bis(phosphonate)-induced bone accumulation in healthy rats.

Last updated on 2021-24-06 at 11:10